ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $584,000 | -90.1% | 137,345 | -85.8% | 0.01% | -88.6% |
| Q3 2017 | $5,910,000 | -6.3% | 964,116 | +10.5% | 0.04% | -17.0% |
| Q2 2017 | $6,307,000 | +693.3% | 872,353 | +481.6% | 0.05% | +783.3% |
| Q1 2017 | $795,000 | -91.7% | 150,000 | -90.1% | 0.01% | -93.3% |
| Q2 2016 | $9,534,000 | +38.2% | 1,508,548 | +20.7% | 0.09% | +42.9% |
| Q1 2016 | $6,900,000 | +80.4% | 1,250,000 | +82.3% | 0.06% | +53.7% |
| Q4 2015 | $3,825,000 | -19.5% | 685,552 | +22.1% | 0.04% | -26.8% |
| Q3 2015 | $4,752,000 | +9.7% | 561,679 | +96.0% | 0.06% | +124.0% |
| Q2 2015 | $4,332,000 | +332.8% | 286,504 | +358.1% | 0.02% | +78.6% |
| Q1 2015 | $1,001,000 | -30.7% | 62,540 | -22.9% | 0.01% | -44.0% |
| Q4 2014 | $1,445,000 | +36.4% | 81,104 | -23.1% | 0.02% | +13.6% |
| Q3 2014 | $1,059,000 | +111.8% | 105,500 | +229.5% | 0.02% | +100.0% |
| Q2 2014 | $500,000 | -66.7% | 32,017 | -60.4% | 0.01% | -73.2% |
| Q1 2014 | $1,501,000 | – | 80,893 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |